Literature DB >> 33112543

Prevalence of Human Polyomavirus JC and BK in Normal Population.

Lila Karimi Dehcheshmeh1, Manoochehr Makvandi1,2, Ali Timori1.   

Abstract

JC virus (JCV) , and BK virus (BKV) can remain latency in kidney and excrete via urine asymptomatically. JCV has been associated with colorectal and bladder cancers. BKV has been linked with lung, pancreas, liver, urogenital tract, head and neck cancers. Therefore, the frequency of JCV DNA and BKV DNA are essential to evaluate in urine samples of healthy individuals.
MATERIALS AND METHODS: Hundred sixty four urine samples were collected from healthy subjects [96 females and 68 males]. DNA was extracted and detection of JCV DNA and BKV DNA was carried out by PCR . The analysis of sequencing and construction of phylogenetic tree were performed for the samples positive for JCV DNA and BKV DNA.
RESULTS: Ten (6.09%) urine samples [5/96(5.2%) females and 5/68( 8.82) males] were tested positive for JCV DNA (P= 0.814). The results of sequencing and phylogenetic tree showed the isolated JCV DNA were cluster with 3A genotype. 21/164 (12.8%) samples were tested positive for BKV DNA [11/96(11.45%) females and males 10/68(14.7%)] ( P= 0.63). The results of sequencing and phylogenetic tree showed that the isolated BKV was cluster with genotype III.
CONCLUSION: In the present study 6.09% and 12.8% of the healthy individuals showed positive for JCV DNA (genotype 3A) and BKV DNA(genotype III) respectively. With regard to life threating diseases by BKV and JCV in immunocomprsied patients , the screening BKV DNA and JCV DNA should be implemented for patients with cancer /autoimmune diseases /organ recipient/ multiple sclerosis (MS), prior to immunosuppression therapy or immunomodulatory agents treatment.<br />.

Entities:  

Keywords:  BK Virus; JC Virus; Polymerase Chain Reaction

Mesh:

Substances:

Year:  2020        PMID: 33112543      PMCID: PMC7798155          DOI: 10.31557/APJCP.2020.21.10.2877

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  39 in total

1.  A Simple and Reliable Strategy for BK Virus Subtyping and Subgrouping.

Authors:  Virginie Morel; Elodie Martin; Catherine François; François Helle; Justine Faucher; Thomas Mourez; Gabriel Choukroun; Gilles Duverlie; Sandrine Castelain; Etienne Brochot
Journal:  J Clin Microbiol       Date:  2017-02-01       Impact factor: 5.948

2.  Bladder cancer and seroreactivity to BK, JC and Merkel cell polyomaviruses: the Spanish bladder cancer study.

Authors:  Claudia Robles; Raphael Viscidi; Nuria Malats; Debra T Silverman; Adonina Tardon; Reina Garcia-Closas; Consol Serra; Alfredo Carrato; Jesús Herranz; Josep Lloreta; Nathaniel Rothman; Francisco X Real; Silvia de Sanjose; Manolis Kogevinas
Journal:  Int J Cancer       Date:  2013-02-27       Impact factor: 7.396

3.  Human polyomaviruses JC and BK in the urine of Brazilian children and adolescents vertically infected by HIV.

Authors:  Daisy Maria Machado; Maria Cristina Fink; Cláudio Sérgio Pannuti; Regina Célia de Menezes Succi; Alessandra Aparecida Machado; Fabiana Bononi do Carmo; Aída de Fátima Barbosa Gouvêa; Paulo Roberto Urbano; Suenia Vasconcelos Beltrão; Isabel Cristina Lopes dos Santos; Clarisse Martins Machado
Journal:  Mem Inst Oswaldo Cruz       Date:  2011-12       Impact factor: 2.743

Review 4.  A cornucopia of human polyomaviruses.

Authors:  James A DeCaprio; Robert L Garcea
Journal:  Nat Rev Microbiol       Date:  2013-03-11       Impact factor: 60.633

5.  Seroepidemiology of the human polyomaviruses.

Authors:  Annika Stolt; Kestutis Sasnauskas; Pentti Koskela; Matti Lehtinen; Joakim Dillner
Journal:  J Gen Virol       Date:  2003-06       Impact factor: 3.891

6.  Genomic typing of BK virus in clinical specimens by direct sequencing of polymerase chain reaction products.

Authors:  L Jin; P E Gibson; J C Booth; J P Clewley
Journal:  J Med Virol       Date:  1993-09       Impact factor: 2.327

7.  High prevalence of the simultaneous excretion of polyomaviruses JC and BK in the urine of HIV-infected patients without neurological symptoms in São Paulo, Brazil.

Authors:  Luiz Henrique da Silva Nali; Cristiane de Campos Centrone; Paulo Roberto Palma Urbano; Augusto César Penalva-de-Oliveira; Jose Ernesto Vidal; Erique Peixoto Miranda; Claudio Sérgio Pannuti; Maria Cristina Domingues da Silva Fink
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2012-08       Impact factor: 1.846

8.  BK and JC virus infections in healthy patients compared to kidney transplant recipients in Tunisia.

Authors:  Hanen Boukoum; Imen Nahdi; Wissal Sahtout; Habib Skiri; Michel Segondy; Mahjoub Aouni
Journal:  Microb Pathog       Date:  2016-06-16       Impact factor: 3.738

Review 9.  The human JC polyomavirus (JCPyV): virological background and clinical implications.

Authors:  Hans H Hirsch; Piotr Kardas; Denise Kranz; Celine Leboeuf
Journal:  APMIS       Date:  2013-06-19       Impact factor: 3.205

10.  Study on JV Virus in Patients with Colon Cancer Typezzm321990Adenocarcinoma

Authors:  Azadeh Haghi Navand; Ali Teimoori; Manoochehr Makvandi; Nilofar Nisi; Seyed Saeid Seyedian; Nastarn Ranjbari; Kambiz Ahmadi Angali; Hadis Keyani; Maryam Tabasi; Keyvan Pourjabari
Journal:  Asian Pac J Cancer Prev       Date:  2019-04-29
View more
  3 in total

Review 1.  BK Polyomavirus-Biology, Genomic Variation and Diagnosis.

Authors:  Jacek Furmaga; Marek Kowalczyk; Tomasz Zapolski; Olga Furmaga; Leszek Krakowski; Grzegorz Rudzki; Andrzej Jaroszyński; Andrzej Jakubczak
Journal:  Viruses       Date:  2021-07-30       Impact factor: 5.048

2.  Molecular Epidemiology and Variation of the BK Polyomavirus in the Population of Central and Eastern Europe Based on the Example of Poland.

Authors:  Jacek Furmaga; Marek Kowalczyk; Olga Furmaga; Christos A Rokos; Tomasz Zapolski; Leszek Krakowski; Andrzej Jakubczak; Sławomir Rudzki
Journal:  Viruses       Date:  2022-01-21       Impact factor: 5.048

3.  BK and JC polyomaviruses and risk of urothelial bladder carcinoma: a preliminary study in the northern shores of Persian Gulf, Iran.

Authors:  Reza Taherkhani; Fatemeh Farshadpour
Journal:  Infect Agent Cancer       Date:  2022-09-19       Impact factor: 3.698

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.